Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies

Author： Rosenoff Stephen  

Publisher： Springer Publishing Company

ISSN： 0941-4355

Source： Supportive Care in Cancer, Vol.12, Iss.8, 2004-08, pp. : 561-570

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Octreotide Treatment of Chemotherapy-induced Diarrhoea

By Ginopoulos P.   Papagiannis T.   Safridi C.   Karvelas F.   Spyropoulos K.   Papadas T.   Gogos C.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 182-183

Elsevier

Access to resources Recommend Favorite

The Clinical Outcome of Chemotherapy-Induced Amenorrhea in Premenopausal Young Patients with Breast Cancer with Long-Term Follow-up

By Jung Minkyu  

Annals of Surgical Oncology, Vol. 17, Iss. 12, 2010-12 ,pp. : 3259-3268

Springer Publishing Company

Access to resources Recommend Favorite

Association of dose escalation of octreotide long‐acting release on clinical symptoms and tumor markers and response among patients with neuroendocrine tumors

By  

Cancer Medicine, Vol. 4, Iss. 6, 2015-06 ,pp. : 864-870

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment

By Vehmanen L.   Saarto T.   Elomaa I.   Makela P.   Valimaki M.   Blomqvist C.  

European Journal of Cancer, Vol. 37, Iss. 18, 2001-12 ,pp. : 2373-2378

Elsevier

Access to resources Recommend Favorite

Oral Ondansetron in the Prevention of Chemotherapy-induced Emesis in Breast Cancer Patients

By Clavel M.   Bonneterre J.   d'Allens H.   Paillarse J.-M.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 15-19

Elsevier

Access to resources Recommend Favorite